πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 23 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12377155

Bicyclic peptide ligands specific for PSMA

BicycleRD Limited Β· Granted Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 12318454

Bicyclic peptide ligands specific for MT1-MMP

BicycleRD Limited Β· Granted Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11912794

Modulation of structured polypeptide specificity

BicycleRD Limited Β· Granted Tue Feb 27 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11814447

Peptide ligands for binding to EphA2

BicycleRD Limited Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11753444

Modulation of structured polypeptide specificity

BicycleRD Limited Β· Granted Tue Sep 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11746126

Bicyclic peptide ligands with detectable moieties and uses thereof

BicycleRD Limited Β· Granted Tue Sep 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11672868

Bicyclic peptide ligands specific for MT1-MMP

BicycleRD Limited Β· Granted Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11623012

Bicyclic peptide ligands specific for EphA2

BicycleRD Limited Β· Granted Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11433137

Compounds for treating cancer

BicycleRD Limited Β· Granted Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11414488

Methods for treating cancer

BicycleRD Limited Β· Granted Tue Aug 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11103591

Bicyclic peptide ligands specific for MT1-MMP

BicycleRD Limited Β· Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10994019

Bicyclic peptide-toxin conjugates specific for MT1-MMP

BicycleRD Limited Β· Granted Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10899798

Bicyclic peptide ligands with detectable moieties and uses thereof

BicycleRD Limited Β· Granted Tue Jan 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10894808

Polypeptide ligands specific for plasma kallikrein

BicycleRD Limited Β· Granted Tue Jan 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10870679

Modulation of structured polypeptide specificity

BicycleRD Limited Β· Granted Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10800813

Modulation of structured polypeptide specificity

BicycleRD Limited Β· Granted Tue Oct 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 08 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10792368

Bicyclic peptide ligands specific for MT1-MMP

BicycleRD Limited Β· Granted Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10624968

Compounds for treating cancer

BicycleRD Limited Β· Granted Tue Apr 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 16 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10532106

Bicyclic peptide ligands specific for MT1-MMP

BicycleRD Limited Β· Granted Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10441663

Methods for treating cancer

BicycleRD Limited Β· Granted Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10294274

Polypeptide ligands specific for plasma kallikrein

BicycleRD Limited Β· Granted Tue May 21 2019 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 16 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10118947

Modulation of structured polypeptide specificity

BicycleRD Limited Β· Granted Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 9994617

Modulation of structured polypeptide specificity

BicycleRD Limited Β· Granted Tue Jun 12 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted